In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Oxford Nanopore brings in $109mm via late-stage funding round

Executive Summary

In what looks to be its Series J financing round, Oxford Nanopore Technologies Ltd. (nanopore-based molecular electronic analysis systems) raised £70mm ($109mm) through the sale of ordinary shares to new and existing investors in the UK, US, and Europe. Proceeds will support product development, manufacturing, and commercialization.
Deal Industry
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register